GF/B50/EDP01
Approved by the Board on: 04 December 2023
Decision on the Secretariat’s Recommendation on Funding from the 2023-2025 Allocation
The Board:
- Approves the funding recommended for each country disease component, and its constituent grants, as listed in Table 1 of GF/B50/ER01 (“Table 1”);
- Acknowledges each country disease component’s constituent grants will be implemented by the proposed Principal Recipients listed in Table 1, or any other Principal Recipient(s) deemed appropriate by the Secretariat in accordance with Global Fund policies;
- Affirms the funding approved under this decision (a) is subject to the availability of funding, and (b) shall be committed in annual tranches; and
- Delegates to the Secretariat authority to redistribute the overall upper-ceiling of funding available for each country disease component among its constituent grants, provided that the Technical Review Panel (the “TRP”) validates any redistribution that constitutes a material change from the program and funding request initially reviewed and recommended by the TRP.
Budgetary Implications
This decision does not have material budgetary implications for operating expenses.